Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
Clinical trial NCT04068103 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04068103
- Sponsor
- NRG Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2023-06-30
- Enrollment
- 635
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.